Related Experiment Videos
Necrobiotic xanthogranuloma with paraproteinemia: an evolving presentation
K A Johnston1, R E Grimwood, J J Meffert
1Department of Dermatology, Wilford Hall Medical Center/PSMD, Lackland Air Force Base, Texas 78236-5300, USA.
Cutis
|June 1, 1997
Summary
Necrobiotic xanthogranuloma is a destructive skin condition often misdiagnosed. This progressive disease may evolve from granulomatous inflammation to xanthogranuloma with paraproteinemia.
Area of Science:
- Dermatology
- Pathology
- Immunology
Background:
- Necrobiotic xanthogranuloma with paraproteinemia (NXG) is a rare, destructive disorder.
- It is frequently misdiagnosed due to overlapping clinical and histological features with other granulomatous and xanthomatous conditions.
- Previously reported under various names, it was first described as NXG in 1980.
Observation:
- A 69-year-old woman presented with pruritic, painful papules, plaques, and nodules.
- Initial biopsies suggested granuloma annulare, followed by changes consistent with necrobiosis lipoidica.
- Subsequent biopsies confirmed necrobiotic xanthogranuloma with coexistent IgG kappa paraproteinemia.
Findings:
- NXG is a progressive, destructive process.
- Histological findings can evolve over time, leading to diagnostic challenges.
- Patients with NXG and monoclonal gammopathy have a 9-11% risk of developing myeloma, amyloidosis, or macroglobulinemia.
Implications:
- Early and accurate diagnosis of NXG is crucial for patient management.
- The proposed evolutionary process suggests a link between granulomatous conditions and xanthogranuloma with paraproteinemia.
- Current treatment regimens are not curative, highlighting the need for further research into effective therapies.